Early detection and modern treatments make cervical cancer one of the most preventable and treatable cancers. Newport Women’s ...

WEDNESDAY, Dec. 11, 2024 (HealthDay News) -- In a clinical practice guideline issued by the American Society for Radiation ...

TUESDAY, Dec. 2, 2025 (HealthDay News) -- In a practice guideline issued by the American Society for Radiation Oncology and published online Nov. 17 in Practical Radiation Oncology, recommendations ...

A daily pill called osimertinib (Tagrisso) is delivering far longer cancer control for adults with unresectable stage 3 EGFR-mutated non-small cell lung cancer after chemoradiation and is now ...

A new lab study exploited a unique aspect of metabolism in glioblastoma to boost the effectiveness of chemoradiation, turning the cancer's properties against itself. When you purchase through links on ...

Both survival and safety outcomes after neoadjuvant immunotherapy appear favorable for appropriate patients with muscle-invasive bladder cancer undergoing chemoradiation. Neoadjuvant immunotherapy in ...

Chemotherapy significantly improves overall and cancer-specific survival in cervical cancer patients undergoing radiotherapy, especially in those aged 65 to 80 years. The benefits of chemotherapy ...

In the first randomized controlled trial of its kind, researchers found that adding chemoradiation to adjuvant chemotherapy did not improve outcomes in patients with resected gallbladder cancer.

SAN FRANCISCO -- Neoadjuvant chemoradiotherapy with or without the investigational PD-1 inhibitor sintilimab significantly increased pathological complete response (pCR) rates compared with ...

Researchers looking to de-intensify radiation treatments for people with early-stage, HPV-associated oropharyngeal cancer to prevent long-term side effects halted a large, randomized phase II/III ...

BARCELONA – Adding preoperative chemoradiation to standard-of-care perioperative chemotherapy did not improve overall or progression-free survival in patients with resectable adenocarcinoma of the ...

Patients with unresectable stage 3 non-small cell lung cancer treated with Tecentriq before and following chemoradiation may derive a survival benefit. Tecentriq (atezolizumab) administered before and ...